Injective (INJ) Price Eyes $5.80 Target After August Buyback Launch Program
Injective remains under short-term selling pressure as bearish technical indicators keep traders cautious, though buyers are watching key resistance levels for signs of a recovery. The networkโs latest community buyback and token burn also reinforce its deflationary model and long-term ecosystem growth.
Read from Source ยท tronweekly.com ↗
This content is automatically aggregated. Full credit goes to the original publisher (tronweekly.com).
